Skip to main content

Invivyd, Inc. (IVVD) Stock

Invivyd, Inc. Stock Details, Movements and Public Alerts

Stock Details

Invivyd, Inc. (IVVD), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NGM.Currently, the stock is trading at $0.54. Over the past 52 weeks, it has ranged between $0.48 and $3.07. This places the current price at 17.6% of its 52-week high and 11.8% above its 52-week low. Recent trading volume was recorded at 2,303,817. The 14-day Relative Strength Index (RSI) stands at 27.86, suggesting oversold conditions. The stock is currently trading below its 50-day moving average of $0.88 by 38.64%. Similarly, it is below its 200-day moving average of $1.62 by 66.67%. The MACD histogram is -0.01, indicating bearish momentum (MACD Line: -0.10, Signal Line: -0.09). There is currently 1 active alert set for IVVD by users.

52-Week Range

$3.07 - $0.48

-82.41% from high · +11.80% from low

Avg Daily Volume

3,397,700

20-day average

100-day avg: 3,935,749

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-0.92

Price to Book

0.75

EV/EBITDA

0.22

EPS (TTM)

-$0.29

Price to Sales

2.82

Beta

0.67

Less volatile than market

Q:How is IVVD valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is IVVD's risk profile compared to the market?
With a beta of 0.67, Invivyd, Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 0.75 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

-138.90%

Operating Margin

-313.85%

EBITDA

$-81,157,000

Return on Equity

-60.34%

Return on Assets

-29.59%

Revenue Growth (YoY)

21.60%

Q:How profitable and efficient is IVVD's business model?
Invivyd, Inc. achieves a profit margin of -138.90%, meaning it retains $-138.90 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -313.85% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -60.34% and ROA at -29.59%, the company achieves moderate returns on invested capital.
Q:What are IVVD's recent growth trends?
Invivyd, Inc.'s revenue grew by 21.60% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. These growth metrics should be evaluated against Biotechnology industry averages for proper context.

Company Size & Market

Market Cap

$157.6M

Revenue (TTM)

$55.87M

Revenue/Share (TTM)

$0.25

Shares Outstanding

294.61M

Book Value/Share

$0.72

Asset Type

EQUITY

Q:What is IVVD's market capitalization and position?
Invivyd, Inc. has a market capitalization of $157.6M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 294.61M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does IVVD's price compare to its book value?
Invivyd, Inc.'s book value per share is $0.72, while the current stock price is $0.54, resulting in a price-to-book (P/B) ratio of 0.75. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$10.00

1751.85% upside potential

Analyst Recommendations

Strong Buy

0

Buy

3

Hold

1

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for IVVD?
4 analysts cover IVVD with 75% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $10.00 implies 1751.9% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on IVVD?
Current analyst recommendations:03 Buy, 1 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Aug 1, 2026, 02:03 AM

Technical Indicators

RSI (14-day)

27.86

Oversold

50-Day Moving Average

$0.88

-38.64% below MA-50

200-Day Moving Average

$1.62

-66.67% below MA-200

MACD Line

-0.10

MACD Signal

-0.09

MACD Histogram

-0.01

Bearish

Q:What does IVVD's RSI value tell investors?
The RSI (Relative Strength Index) for IVVD is currently 27.86, indicating the stock is in oversold territory (below 30). This indicates heavy selling pressure that may have pushed the price too low too fast. Oversold readings can present buying opportunities, but stocks can remain oversold in strong downtrends. Look for RSI to rise above 30 as a potential recovery signal. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret IVVD's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.10 below the signal line at -0.09, with histogram at -0.01. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.88) is below the 200-day MA ($1.62), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Aug 1, 2026, 01:22 AM

Active Alerts

Alert Condition
Price increases by
Threshold
25%
Created
Nov 19, 2025, 01:02 PM

Stay Ahead of the Market with Invivyd, Inc. Alerts

Set up price alerts for Invivyd, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.